Pricing Log in Create free account

Cue Biopharma, Inc. (CUE) vs Korro Bio, Inc. (KRRO)

Cue Biopharma, Inc. and Korro Bio, Inc. are both Biotechnology companies. Cue Biopharma, Inc. and Korro Bio, Inc. are of similar size ($137.1M and $135.6M). Cue Biopharma, Inc. grew revenue faster over the last twelve months: 354.4% against −81.9%. Korro Bio, Inc. has the higher net margin (0.00% vs −435.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Korro Bio, Inc. leads on 10 and Cue Biopharma, Inc. on 4.

Valuation

Metric CUE KRRO Biotechnology median
P/E n/m n/m 8.50
P/S 2.81 23.51 9.71
P/B 45.87 1.46 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.40 8.38 9.21
Earnings yield (161.71%) (117.23%) (33.15%)
Free cash flow yield (47.31%) (45.42%) (25.50%)

Profitability

Metric CUE KRRO Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (262.03%) 0.00% 0.00%
Net margin (435.83%) 0.00% 0.00%
Free cash flow margin (133.13%) 0.00% 0.00%
Return on equity (1,603.48%) (97.69%) (56.36%)
Return on assets (459.60%) (62.03%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CUE KRRO Biotechnology median
Revenue growth (TTM) 354.37% (81.87%) 6.02%
EPS growth (last fiscal year) 61.11% (33.19%) 30.26%
Revenue growth, 5-year CAGR 54.16% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CUE KRRO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.25 9.55 4.72
Net debt to EBITDA 1.10 0.64 0.96

Dividend

Metric CUE KRRO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CUE KRRO Biotechnology median
Market cap 135.63m 137.09m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack